Epigenic Therapeutics logo

Epigenic Therapeutics jobs and careers

China

About Epigenic Therapeutics

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists focused on discovering gene editing technologies and developing gene editing therapies, the company has multiple product candidates in the pipeline, including treatment for metabolic, cardiovascular, viral hepatitis, ocular and rare diseases.

Founded
2021
Employees
11 to 50
Total funding
$52M
Headquarters
China

Leadership

The top of Epigenic Therapeutics's org chart, with how many people report into each leader.

BZ

Bob Zhang

CEO, Co-founder